Paralytic myopathy - A leading clinical presentation for primary aldosteronism in Taiwan

被引:24
|
作者
Huang, YY [1 ]
Hsu, BRS [1 ]
Tsai, JS [1 ]
机构
[1] CHANG GUNG MEM HOSP, CHANG GUNG MED CTR, DIV ENDOCRINOL & METAB, TAOYUAN, TAIWAN
来源
关键词
D O I
10.1210/jc.81.11.4038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Between 1982 and 1995, 43 cases of primary aldosteronism, 36 cases of adenoma, and 7 cases of hyperplasia were treated in Chang Gung Medical Center. Twenty-one of these (49%) presented with muscular paralysis as an initial symptom (categorized as the paralytic group). Seven patients in the paralytic group (33%) had extra-limb muscle involvement. Six of them presented with bulbar palsy and one patient had a peripheral-type facial palsy. The serum potassium levels in the paralytic group were significantly lower than those of the nonparalytic group (1.8 +/- 0.3 vs. 2.3 +/- 0.4 mmol/L, P = 0.0001). There were no significant differences in blood pressure or the serum aldosterone level between the two groups. Provocative factors such as a high carbohydrate diet, vigorous exercise, or seasonal variation did not appear to play a significant role in inducing the symptoms. Paralytic myopathy appears to be more common in Oriental people. The symptom is rarely reported among western populations. Primary aldosteronism should be considered in patients presenting with neuromuscular weakness associated with hypokalemia, regardless of the degree of hypertension.
引用
收藏
页码:4038 / 4041
页数:4
相关论文
共 50 条
  • [1] Paralysis: The leading presentation for primary aldosteronism in Taiwan?
    Chiang, WC
    Lin, SL
    Chen, YM
    Wu, KD
    Hsieh, BS
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07): : 2377 - 2378
  • [2] SEVERE HYPOKALEMIC MYOPATHY AS THE PRESENTATION OF PRIMARY ALDOSTERONISM
    PAJA, M
    ESTRADA, FJ
    BLANCO, C
    LUCAS, T
    MEDICINA CLINICA, 1992, 99 (06): : 234 - 234
  • [3] Treatment of primary aldosteronism: Clinical practice guidelines of the Taiwan Society of Aldosteronism
    Tseng, Chi-Shin
    Chan, Chieh-Kai
    Lee, Hsiang-Ying
    Pan, Chien-Ting
    Peng, Kang-Yung
    Wang, Shuo-Meng
    Huang, Kuo-How
    Tsai, Yao-Chou
    Wu, Vin-Cent
    Chueh, Jeff S.
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2024, 123 : S125 - S134
  • [4] MYOPATHY AND PRIMARY HYPER-ALDOSTERONISM
    SCHADY, W
    YUILL, GM
    NEUROLOGY, 1981, 31 (02) : 225 - 226
  • [5] Clinical presentation and surgical outcomes in primary aldosteronism differ by race
    Gershuni, Victoria M.
    Ermer, Jae P.
    Kelz, Rachel R.
    Roses, Robert E.
    Cohen, Debbie L.
    Trerotola, Scott O.
    Fraker, Douglas L.
    Wachtel, Heather
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 121 (03) : 456 - 464
  • [6] MYOPATHY AND PRIMARY HYPER-ALDOSTERONISM - REPLY
    ATSUMI, T
    NEUROLOGY, 1981, 31 (02) : 226 - 226
  • [7] Primary Aldosteronism Complicated by Severe Hypokalemic Myopathy
    Arakawa, Nobuhito
    Eguchi, Kazuo
    Ogawa, Tomoko
    Hashimoto, Ritsuo
    Kato, Hiroyuki
    ENDOCRINOLOGIST, 2010, 20 (06): : 298 - 300
  • [8] Hypokalemic myopathy in primary aldosteronism: A case report
    Wu, Chuifen
    Xin, Jun
    Xin, Minghua
    Zou, Hai
    Jing, Lie
    Zhu, Caoyong
    Lei, Wenhui
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (06) : 4064 - 4066
  • [9] Targeted treatment of primary aldosteronism - The consensus of Taiwan Society of Aldosteronism
    Huang, Kuo-How
    Yu, Chih-Chin
    Hu, Ya-Hui
    Chang, Chin-Chen
    Chan, Chieh-Kai
    Liao, Shih-Cheng
    Tsai, Yao-Chou
    Chueh, Shih-Chieh Jeff
    Wu, Vin-Cent
    Lin, Yen-Hung
    Lin, Jui-Hsiang
    Wang, Wei-Jie
    Wu, Che-Hsiung
    Er, Leay Kiaw
    Chang, Chia-Hui
    Chang, Ya-Li
    Ho, Yi-Luwn
    Chang, Hung-Wei
    Lin, Lian-Yu
    Hu, Fu-Chang
    Liu, Kao-Lang
    Wang, Shuo-Meng
    Lu, Ching-Chu
    Yen, Ruoh-Fang
    Wu, Kwan-Dun
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2019, 118 (01) : 72 - 82
  • [10] Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism
    Araujo-Castro, Marta
    Parra, Paola
    Rojas-Marcos, Patricia Martin
    Fano, Miguel Paja
    Boillos, Marga
    Pascual-Corrales, Eider
    Cano, Ana Maria Garcia
    Ruiz-Sanchez, Jorge Gabriel
    Delgado, Almudena Vicente
    Hoyos, Emilia Gomez
    Ferreira, Rui
    Sanz, Inigo Garcia
    Sala, Monica Recasens
    Millan, Rebeca Barahona San
    Cesar, Maria Jose Picon
    Guardiola, Patricia Diaz
    Perdomo, Carolina M.
    Manjon-Miguelez, Laura
    Centeno, Rogelio Garcia
    Rebollo Roman, Angel
    Gracia Gimeno, Paola
    Robles Lazaro, Cristina
    Morales-Ruiz, Manuel
    Calatayud, Maria
    Furio Collao, Simone Andree
    Meneses, Diego
    Nunez, Miguel Sampedro
    Quesada, Veronica Escudero
    Ribas, Elena Mena
    Sanchez, Alicia Sanmartin
    Gonzalvo Diaz, Cesar
    Lamas, Cristina
    Tous, Maria del Castillo
    Gotarredona, Joaquin Serrano
    Michalopoulou Alevras, Theodora
    Mateo, Eva Maria Moya
    Hanzu, Felicia A.
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15